Group 1 - The stock of Yipinhong Pharmaceutical Group Co., Ltd. fell by 5.01% on January 15, closing at 39.66 yuan per share, with a trading volume of 562 million yuan and a turnover rate of 3.32%, resulting in a total market capitalization of 17.914 billion yuan [1] - Yipinhong was established on February 4, 2002, and went public on November 16, 2017. The company is located in Guangzhou, Guangdong Province, and its main business includes the research, production, and sales of proprietary drugs, as well as the sales of agency drugs [1] - The revenue composition of Yipinhong's main business includes 61.12% from pediatric drugs, 22.71% from chronic disease drugs, and 16.17% from other products [1] Group 2 - According to data from the top ten heavy stocks of funds, one fund under Huaxia Fund holds a significant position in Yipinhong. The Huaxia New Jinhui Mixed A Fund (004048) held 23,000 shares in the third quarter, accounting for 2.58% of the fund's net value, making it the sixth-largest heavy stock [2] - The Huaxia New Jinhui Mixed A Fund was established on March 8, 2017, with a latest scale of 14.8028 million. Year-to-date, it has lost 0.49%, ranking 8631 out of 8840 in its category; over the past year, it has gained 13.41%, ranking 6028 out of 8094; and since inception, it has achieved a return of 15.81% [2] - The fund manager of Huaxia New Jinhui Mixed A is Hu Jie, who has been in the position for 2 years and 286 days, with the total asset scale of 52.9889 million yuan. The best fund return during his tenure is 6.22%, while the worst is 5.93% [2]
一品红股价跌5.01%,华夏基金旗下1只基金重仓,持有2.3万股浮亏损失4.81万元